Type 1 diabetes trials in Argentina

In Argentina 6 Also abroad 539

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Buenos Aires, Córdoba, Mar del Plata, Salta, San Miguel de Tucumán, Santa Fe
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Bahía Blanca, Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Godoy Cruz, Mar del Plata, Rosario, San Juan, San Miguel de Tucumán, San Rafael
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Where
Buenos Aires
Age
18 years and over
People
145
Run by
Hospital Italiano de Buenos Aires
See details and how to joinNCT07621419